期刊文献+

Quality of life in rectal cancer surgery:What do the patient ask? 被引量:1

Quality of life in rectal cancer surgery:What do the patient ask?
下载PDF
导出
摘要 Rectal cancer surgery has dramatically changed with the introduction of the total mesorectal excision(TME), which has demonstrated to significantly reduce the risk of local recurrence. The combination of TME with radiochemotherapy has led to a reduction of local failure to less than 5%. On the other hand, surgery for rectal cancer is also impaired by the potential for a significant loss in quality of life. This is a new challenge surgeons should think about nowadays: If patients live more, they also want to live better. The fight against cancer cannot only be based on survival, recurrence rate and other oncological endpoints. Patients are also asking for a decent quality of life. Rectal cancer is probably a paradigmatic example: Its treatment is often associated with the loss or severe impairment of faecal function, alteration of body anatomy, urogenital problems and, sometimes, intractable pain. The evolution of laparoscopic colorectal surgery in the last decades is an important example, which emphasizes the importance that themes like scar, recovery, pain and quality of life might play for patients. The attention to quality of life from both patients and surgeons led to several surgical innovations in the treatment of rectal cancer: Sphincter saving procedures, reservoir techniques(pouch and coloplasty) to mitigate postoperative faecal disorders, nerve-sparing techniques to reduce the risk for sexual dysfunction. Even more conservative procedures have been proposed alternatively to the abdominal-perineal resection, like the local excisions or transanal endoscopic microsurgery, till the possibility of a wait and see approach in selected cases after radiation therapy. Rectal cancer surgery has dramatically changed with the introduction of the total mesorectal excision(TME), which has demonstrated to significantly reduce the risk of local recurrence. The combination of TME with radiochemotherapy has led to a reduction of local failure to less than 5%. On the other hand, surgery for rectal cancer is also impaired by the potential for a significant loss in quality of life. This is a new challenge surgeons should think about nowadays: If patients live more, they also want to live better. The fight against cancer cannot only be based on survival, recurrence rate and other oncological endpoints. Patients are also asking for a decent quality of life. Rectal cancer is probably a paradigmatic example: Its treatment is often associated with the loss or severe impairment of faecal function, alteration of body anatomy, urogenital problems and, sometimes, intractable pain. The evolution of laparoscopic colorectal surgery in the last decades is an important example, which emphasizes the importance that themes like scar, recovery, pain and quality of life might play for patients. The attention to quality of life from both patients and surgeons led to several surgical innovations in the treatment of rectal cancer: Sphincter saving procedures, reservoir techniques(pouch and coloplasty) to mitigate postoperative faecal disorders, nerve-sparing techniques to reduce the risk for sexual dysfunction. Even more conservative procedures have been proposed alternatively to the abdominal-perineal resection, like the local excisions or transanal endoscopic microsurgery, till the possibility of a wait and see approach in selected cases after radiation therapy.
出处 《World Journal of Gastrointestinal Surgery》 SCIE CAS 2015年第12期349-355,共7页 世界胃肠外科杂志(英文版)(电子版)
关键词 Quality of life RECTAL cancer Laparoscopicsurgery SPHINCTER PRESERVATION NERVE-SPARING Quality of life Rectal cancer Laparoscopic surgery Sphincter preservation Nerve-sparing
  • 相关文献

参考文献68

  • 1Heald RJ, Husband EM, Ryall RD. The mesorectum in rectalcancer surgery--the clue to pelvic recurrence- Br J Surg 1982; 69:613-616 [PMID: 6751457 DOI: 10.1002/bjs.1800691019].
  • 2Heald RJ, Ryall RD. Recurrence and survival after totalmesorectal excision for rectal cancer. Lancet 1986; 1: 1479-1482[PMID: 2425199 DOI: 10.1016/S0140-6736(86)91510-2].
  • 3Quirke P, Durdey P, Dixon MF, Williams NS. Local recurrenceof rectal adenocarcinoma due to inadequate surgical resection.Histopathological study of lateral tumour spread and surgicalexcision. Lancet 1986; 2: 996-999 [PMID: 2430152].
  • 4Sauer R, Becker H, Hohenberger W, Rel C, Wittekind C,Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, Karstens JH, Liersch T, Schmidberger H, Raab R. Preoperative versuspostoperative chemoradiotherapy for rectal cancer. N Engl JMed 2004; 351: 1731-1740 [PMID: 15496622 DOI: 10.1056/NEJMoa040694].
  • 5Hoerske C, Weber K, Goehl J, Hohenberger W, Merkel S. Longtermoutcomes and quality of life after rectal carcinoma surgery.Br J Surg 2010; 97: 1295-1303 [PMID: 20602501 DOI: 10.1002/bjs.7105].
  • 6Fleshman J, Sargent DJ, Green E, Anvari M, Stryker SJ, BeartRW, Hellinger M, Flanagan R, Peters W, Nelson H. Laparoscopiccolectomy for cancer is not inferior to open surgery based on5-year data from the COST Study Group trial. Ann Surg 2007; 246:655-662; discussion 662-664 [PMID: 17893502 DOI: 10.1097/SLA.0b013e318155a762].
  • 7Colon Cancer Laparoscopic or Open Resection Study Group;Buunen M, Veldkamp R, Hop WC, Kuhry E, Jeekel J, HaglindE, P-hlman L, Cuesta MA, Msika S, Morino M, Lacy A, BonjerHJ. Survival after laparoscopic surgery versus open surgery forcolon cancer: long-term outcome of a randomised clinical trial.Lancet Oncol 2009; 10: 44-52 [PMID: 19071061 DOI: 10.1016/S1470-2045(08)70310-3].
  • 8Jayne DG, Guillou PJ, Thorpe H, Quirke P, Copeland J, SmithAM, Heath RM, Brown JM. Randomized trial of laparoscopicassistedresection of colorectal carcinoma: 3-year results of the UKMRC CLASICC Trial Group. J Clin Oncol 2007; 25: 3061-3068[PMID: 17634484 DOI: 10.1200/JCO.2006.09.7758].
  • 9Lacy AM, Delgado S, Castells A, Prins HA, Arroyo V, IbarzabalA, Pique JM. The long-term results of a randomized clinical trialof laparoscopy-assisted versus open surgery for colon cancer. AnnSurg 2008; 248: 1-7 [PMID: 18580199 DOI: 10.1097/SLA.0b013e31816a9d65].
  • 10Bonjer HJ, Deijen CL, Abis GA, Cuesta MA, van der Pas MH,de Lange-de Klerk ES, Lacy AM, Bemelman WA, Andersson J,Angenete E, Rosenberg J, Fuerst A, Haglind E. A randomizedtrial of laparoscopic versus open surgery for rectal cancer. N EnglJ Med 2015; 372: 1324-1332 [PMID: 25830422 DOI: 10.1056/NEJMoa1414882].

同被引文献6

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部